ArticleBMC geriatrics2025
Development of a sarcopenic obesity risk prediction model for older adults based on the CHARLS database.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectiveTo construct a risk prediction model for sarcopenic obesity in the elderly using different machine learning methods.
methodsThe research data were derived from the CHARLS 2015 national survey data. According to the inclusion and exclusion criteria, 2,375 elderly people were selected and 42 research variables were included. The risk factors were screened by univariate analysis. The variables with statistically significant differences (P < 0.05) were selected using the Boruta feature selection method, resulting in 16 features. A prediction model was then constructed based on six machine learning algorithms. The model was comprehensively evaluated using the area under the receiver operating characteristic curve (AUROC), accuracy, recall, precision, F1 score, and Brier score. The interpretable analysis of the optimal machine learning model was performed with SHAP(Shapley Additive Explanations.
resultsAmong the six models, XGBoost had the best comprehensive performance, with an AUC of 0.78, accuracy of 0.89, recall of 0.20, precision of 0.53, F1 score of 0.28, and Brier score of 0.11. The importance analysis of shap features showed that waist circumference, pace and uric acid were important risk factors.
conclusionThe model constructed by XGBoost machine learning algorithm has the best predictive performance, which may facilitate for early clinical evaluation and prevention of sarcopenic obesity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.